A Deep Dive into a Amarin (AMRN) Takeover, Other Scenarios
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NCE Decision Again Upon Amarin (AMRN); Could Be a 5-Bagger in a Takeover
October 5, 2012 1:41 PM EDTWith shares of Amarin Corporation (NASDAQ: AMRN) down over 20 percent in the past few months investors may be thinking the market has missed the fact that the FDA approved the company's Vascepa for very high triglycerides in July. But the truth is - it didn't. The ever-allusive NCE status has been the culprit... More
